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If each cell type is deﬁned by the genes it expresses, then onewould
expect every cell type to show a distinct pattern of expression, charac-
terizing that cell type. Such cell type-speciﬁc knowledge is important
for advancing our basic understanding of biology and as a useful starting
point for drug discovery. Such knowledge also sheds light on how one
might reprogram one cell type in to another—a major hurdle in the
process of direct reprogramming (Vierbuchen et al., 2010). However,
elucidating a unique expression pattern for each cell type requires
comparisons across a broad set of cell types. If one were to compare
only ﬁbroblasts to neurons, for example, one would ﬁnd unique
signatures distinguishing these cell types from each other, but not
from other cells. Therefore, data-derived comparative signatures are
context-dependent—subject to the diversity of cell types included in
the comparison. Ignoring the context-dependency has led previous
analyses astray—many genes that were identiﬁed as being expressed
speciﬁcally in a particular cell type (i.e., markers for that cell type),
were later found to be expressed in several different cell types (Juuri
et al., 2012).
Onewould expect thatwith an increasing number and variety of cell
types, recovered cell-speciﬁc signatures would become more reﬁned,
and eventually plateau as the amount of data within each cell type
added becomes less informative. Herein, we show that as we add
more and more data from various cell states to our analysis, the set of
identiﬁed core expression factors initially changed rapidly, and thenoung Drive South Box 160606,
. This is an open access article underbecame more stable. Our goal here was to deﬁne cell states, including
those representing various developmental stages, in a context-
independent manner, by using a newly-generated, cell-state speciﬁc
compendium of gene expression.
A secondary goal was to ﬁnd the unique regulatory core for each cell
state—the elementswhich drive andmaintain cell fate (Kim et al., 2008;
Wang et al., 2006). Direct reprogrammingof cells (e.g., fromﬁbroblast to
PSC), has shown that overexpression of a small number of transcription
factors can drive a cell to become a completely different type of cell
(Takahashi and Yamanaka, 2006). This direct reprogramming approach
is quickly serving to identify robust transcriptional networks that drive
particular cell fates, even when introduced into cells of a different germ
layer. However, identifying these core expression factors has typically
taken years of painstaking effort. Normally, the ﬁrst step in identifying
these small groups of cell fate drivers is to compare the gene expression
of just two types of cells (or against several others in aggregate),
and then to select the most upregulated transcription factors in the
desired cell type. Next, through trial and error, cocktails of successful
reprogramming factors (not necessarily unique) can sometimes be
identiﬁed (Takahashi and Yamanaka, 2006; Vierbuchen et al., 2010).
This overall approach has been hampered by the selection of factors
based on expression differences between just two cell types (or based
on comparing one cell type to several others in aggregate). Thus, our
second goal was to streamline this type of reprogramming pre-
selection process by obtaining a more reﬁned comparison as a result
of using a broader data set. We have named our overall approach,
CEMA, for Core Expression Module Analysis.
Using a cell-state-by-cell-state logistic regression-based approach
(similar in spirit to a one way analysis-of-variance with post hoc
analysis), we identiﬁed putative core elements of cell-speciﬁc transcrip-
tion for 17 cell states representing nine unique puriﬁed human cellthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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mental age (including neural progenitor cells, ﬁbroblasts, keratinocytes,
hepatocytes, mesothelial cells, myoepithelial cells, kidney epithelial
cells, pluripotent stem cells, deﬁnitive endoderm, smooth muscle cells,
and endothelial cells) (Chin et al., 2009; Chin et al., 2010; Patterson
et al., 2012). This collection of data represents an improvement over
previously described databases (e.g., BioGPS (Wu et al., 2009)) in that
we used strictly puriﬁed cells from tissue as opposed to whole tissues,
and all the analyses were carried out in the same lab to minimize
batch effect. In addition, data from cells differentiated from human plu-
ripotent stem cells were included along with tissue-derived counter-
parts, opening the possibility of identiﬁcation of gene expression
patterns that change across developmental stages. Finally, our collection
also included the same cell type (endothelial) derived from different lo-
cations within the body to provide information on regional specializa-
tion. The detailed list of cell states is provided in Table 1, along with
corresponding shorthand notation used throughout the paper. We
also make use of an independent and publically available data set
consisting of 84 different cell types and tissues to validate our results.
We found that many common “marker” genes typically used to de-
ﬁne various cell types of the nervous system were in fact expressed in
many cells not associated with brain or spinal cord (Pankratz et al.,
2007; Zhao et al., 2004). For example, NESTINwas highly expressed in
7 out of 17 cell states. We also show how identiﬁed core expression
modules changed during development or as a result of spatial speciﬁca-
tion in different tissues. Using results generated from this approach, we
built an interactive web-based application for dissemination and explo-
ration of our results, yielding a valuable resource with a novel perspec-
tive on human cell fate, as well as potential leads for inducing one cell
state from another. As validation that our approaches can yield factors
important for particular cell fates, we provide evidence that CEMA-
predicted factors can indeed drive cell fate.
2. Results
2.1. Applying CEMA
Application of our approach, CEMA (see Statistical analysis,
Materials and methods section), allowed for the identiﬁcation of a
relatively small number of genes that serve to uniquely distinguish
each type of cell from every other (the top 10 displayed in Fig. 1A;
also shown in Supplementary Table 1 with relative expression valuesTable 1
Each of the 17 cell states in our compendium, alongwith the shorthandused inﬁgures and
on the website (in parentheses). Also denoted in parentheses is the number of indepen-
dent biological replicates analyzed.
1 Tissue endothelial cell EC (blood vessel) (×10)




3 Pluripotent derived ﬁbroblast cell PSC-FB (paraxial mesoderm) (×8)
4 Pluripotent derived hepatocyte cell PSC-HEP (hepatocyte) (×4)
5 Pluripotent derived neuron cell PSC-NEU (neuron) (×3)
6 Pluripotent derived neural progenitor
cell
PSC-NPC (neural tube progenitor)
(×13)
7 Tissue smooth muscle cell SMC (smooth muscle) (×4)
8 Squamous cell carcinoma cell lines SSC (squamous cell carcinoma) (×4)
9 Tissue derived ﬁbroblast cell tis-FB (paraxial) (×9)
10 Tissue derived hepatocyte cell tis-HEP (hepatocyte) (×3)
11 Tissue derived keratinocyte cell tis-KER (keratinocyte) (×6)
12 Tissue derived kidney epithelial cell tis-KID (kidney proximal tubule)
(×2)
13 Tissue derived mesothelial cells tis-MESO (mesothelial cell) (×2)
14 Tissue derived myoepithelial cell tis-MYOEP (myoepithelial) (×4)




16 Tissue derived neural progenitor
cell 15–19 PCW
tis-NPC-late (mid-gestational) (×5)
17 Undifferentiated pluripotent stem cells Undiff (model of epiblast) (12)(RMA normalized, log2)). We present the output of results as a dendro-
gram (see the Materials and methods section) comparing the CEMA
output from all the different cell states (Fig. 1B). The CEMA proﬁles ap-
peared to cluster almost as expected considering their developmental
background and state of differentiation. This was also true when we re-
stricted the analysis to transcription factors (Fig. 1C), raising the possi-
bility that cells can be distinguished by their core transcription factor
(TF) expression, an idea consistent with the fact that most proteins in
“reprogramming” cocktails identiﬁed to date are TFs (e.g. the Yamanaka
factors for re-programming ﬁbroblasts to pluripotent cells) (Takahashi
and Yamanaka, 2006).
It should also be noted that the vertical lines of the dendrograms are
quite long, indicating low similarity—to be expectedwhen a broad com-
pendium is used. Furthermore, although CEMA implicitly is designed to
focus on ﬁnding genes that are expressed in a single cell state (one vs
all), the approach is still ﬂexible enough to allow for the same gene
showing up inmultiple cell states. As an example of this, FABP7was rep-
resented on all three lists of neural progenitor cells (NPC), but was only
found with HMGB1 in one NPC state (tissue-NPC early).
As increasingly diverse cell stateswere added to the analysis, we ex-
pected that the speciﬁcity of each list would be reﬁned. An illustrative
example of this reﬁnement can be seen in Fig. 1D, which shows a sum-
mary plot of how the analysis changed as we increased the number of
cell types in the comparison from two through eight. When just two
cell types were compared, they were distinguished by 1000s of genes,
but once ﬁve cell types were included in the comparison, the number
of unique genes plateaued, presumably owing to a fairly broad compen-
dium having already been used at that point. In our ﬁnal analysis, we
used 17distinct cell states and produced sets of 20–700genes expressed
in unique combinations in each cell state. These results stand in stark
contrast to the roughly 3000–7000 genes we found differentially
expressed between any two of these cell states.
To determine the relative speciﬁcity of the CEMA output, we ﬁrst
looked at the pattern of the most highly expressed genes in a particular
cell type (NPC), in an expression database containing data for 84 cell
types and tissues (BioGPS (Wu et al., 2009)). Such an examination
revealed that simply taking the magnitude of gene expression into
account is ineffective at uncovering cell state speciﬁc genes (Fig. 1D,
and Fig. S1). Instead, sorting for high gene expression within the
CEMA reﬁned gene list, produced genes with very high speciﬁcity
when analyzed on an independent data set (BioGPS) (Fig. S1). For in-
stance, FABP7 was a top CEMA gene in PSC- and tissue-derived NPCs
(Fig. 1E), and the only positive signal from the BioGPS database that
was found in the brain (Fig. S1). Using a similar analysis for hepatocytes
further demonstrated the speciﬁcity of the CEMA output. In this case,
the top genes identiﬁed by CEMA in pluripotent derived hepatocytes
showed up as more speciﬁc to the fetal liver than any other cell type
in the database (Fig. S2A). Furthermore, CEMA analysis on hepatocytes
taken from the adult liver yielded genes that appeared as a group to
be more speciﬁc to the adult liver than the fetal liver (Fig. S2B).
2.2. Temporal and spatial analyses
As cells develop from a pluripotent stage through various levels of
speciﬁcation and differentiation, it is likely that their core expression
factors change. To uncover such factors for a particular cell lineage, we
analyzed different cell types in the neural lineage, each representing a
different developmental time point. These cell states were described
previously to represent different stages of gestational development
based on gene expression and functional criteria (neurogenic versus
gliogenic) (Patterson et al., 2012). This gestational timing model was
further validated by work showing that PSC-NPCs develop in vitro at a
similar rate as they would in vivo (Marin, 2013; Maroof et al., 2013;
Nicholas et al., 2013).
We ﬁrst identiﬁed all genes using CEMA and found that the resulting
CEMA proﬁles follow the expected segregation (Fig. 2A). To enrich for
Fig. 1. Analysis of 17 cell states produces unique expression modules. (A) A table of the top 10 genes from each cell state shown. (B) and (C) Dendrograms showing the relationship
between all tissues in the global analysis, using the correlation between their p-values for all genes (B) or just transcription factors (C). Note that, in general, the CEMA patterns for
similar cell states appeared to be more similar for expected cell states. In other words, the list of genes ranked by their speciﬁcity for a particular cell state reﬂected the similarity that
would be uncovered by a Pearson-type correlation. (D) Example of how the p-values stabilized as we added more and more cell types In particular, each entry on the x-axis shows the
correlation between tis-HEP p-values, when X tissues, or X + 1 tissues were used. For example, the 2:3 entry shows that when only two tissues were used, as compared to three
tissues, the p-values have a correlation of around 0.75. However, when we compared the p-values when 8 tissues were used, as compared to 7 (7:8) we see that the correlation
approaches 1. Here, the order of tissues added for comparison with tis-HEP were: tis-FB then tis-HEP, tis-KER, tis-MYOEP, tis-KID, tis-MESO, tis-NPCe, and tis-NPC. (E) To assess the
speciﬁcity of CEMA-identiﬁed genes, an example gene for NPCs was probed across the BioGPS database of proﬁled cell types from across dozens of cell types. FABP7, identiﬁed by
CEMA as speciﬁc to tis-NPCs, only showed up in fetal brain samples in the Novartis data set. Note that just a subset of cell types are labelled in the image (blue text), while the analysis
was performed on all cell types. A broader analysis is available in Fig. S1.
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for transcription factors (Fig. 2B). Note that each time point is character-
ized by a different set of TFs, rather than by the same sets changing in
magnitude (Fig. 2B), indicating a change in mechanism rather than
amount, consistent with what is known to happen over time as
Yamanaka factors are induced in ﬁbroblasts. Although the statistical
analysis seeks out such differences, it is nevertheless interesting to
note that it in this case itﬁnds them.While some core expression factors
are found across multiple time points, each time stage is, in its entirety,
distinct. In addition, while all the NPCs analyzed expressed signiﬁcantlevels of typical NPC markers (SOX2, NESTIN, MUSASHI, CD133, SOX1
and PAX6) (Patterson et al., 2012), they are distinguished by key sets
of transcription factors which presumably endow them with different
functional capacities. This is typiﬁed by the fact that the PSC-NPCs pro-
ﬁled are highly neurogenic, while the tis-NPCs analyzed are mostly
gliogenic (Patterson et al., 2012).
To uncover differences between core expression modules in the
same cell type puriﬁed from different portions of the human body,
we isolated endothelial cells from the vasculature of various regions
(coronary (HCA), umbilical (HUV and HUA), aortic (HAO), and dermal
Fig. 2. Temporal and spatial CEMA analyses. (A) Using correlation based on all genes, (B) using only those genes labeled as transcription factors (see theMaterials andmethods section). In
green, the top 10 transcription factors that distinguish each cell type are highlighted. Spatial CEMA analysis. (C) Dendrograms showing the relationship between all tissues in the spatial
analysis, using the correlation between their p-values using correlation based on all genes or, (D) using only those genes labeled as transcription factors (see the Materials and methods
section). In green, the top transcription factors that distinguish each cell type are highlighted.
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ious tissues highlighted a spatial dependence of core expression factors
(Fig. 2C), pointing to variability in their physiology. While all these en-
dothelial cells express very high levels of markers such as VWF and
PECAM, there are signiﬁcant differences in both their total gene and
TF speciﬁc core expression factors that distinguish them not only from
non-endothelial cells, but also from each other (Fig. 2D). Here, CEMA
identiﬁed key factors that distinguished endothelial cells taken from
different tissues with high resolution.
2.3. Finding more consistent constitutive genes
CEMA analysis yielded identiﬁcation of genes with unique expres-
sion patterns. However, we postulated that this compendium of cell
types should allow for the identiﬁcation of genes that are the least var-
iant across many cell types. These genes could then potentially be used
to serve as housekeeping control for RT-PCR, western blotting, and so
on. First, a list of typically-used housekeeping genes (Gur-Dedeoglu
et al., 2009) was analyzed for variability of expression (standard devia-
tion) across the 17 cell types. Ranking just these typical housekeepinggenes to ﬁnd those with the least variance of expression across the 17
cell types, we found that RPL41, coding for a ribosomal protein was
the least variant across the data set, more so than either GAPDH or
βACTIN, the most frequently used housekeeping genes in the literature
(Fig. S3A). Furthermore, when instead all genes on the array were
assayed for the least variability across these cell types, RPL41 again
came up as the least variant gene (Fig. S3B). For some applications it
could be more accurate to use a housekeeping gene for normalization
that is closer in expression level to the gene one is studying. Thus, we
separated out the aforementioned analyses to provide candidate house-
keeping geneswithin different levels of absolute expression (low,medi-
um and high expression) (Fig. S3B–D).
2.4. Dissemination to the scientiﬁc community
To provide general access to our results, a web-based application
was developed, intended both for dissemination of our results, as well
as to provide a data-driven roadmap for human cell states (www.
cemagenes.com). As of now, the website contains template nodes for
most known cell types, with populated nodes for those cell types that
716 I. Germanguz et al. / Stem Cell Research 16 (2016) 712–724have been analyzed thus far. Results restricted to only transcription fac-
tors were also generated (Fig. S4A and B). The application also allows
one to display histograms of the relative expression of individual
genes of interest across all cell types analyzed (Fig. S4C). At regular in-
tervals we expect to add data for additional cell types, whichwill gener-
ate reﬁned CEMA lists for all cell types analyzed to that point, while
maintaining previous versions of the analysis to monitor change over
various iterations.2.5. Evidence that CEMA-identiﬁed modules can drive cell fate
To demonstrate that CEMA identiﬁed factors can deﬁne cell fate, we
designed a system that would allow for a determination of whether
these factors can either reprogram cell fate between somatic cell
types, or program the cell fate of human pluripotent stem cells. The
factors that were used for cell fate experiments were ﬁrst chosen
based on their speciﬁcity to the target cell type as identiﬁed by the
CEMA algorithm. We then sorted them by relative expression level in
the target cell. Finally, we identiﬁed those that are bona ﬁde TFs, as
TFs are well established to play a profound role in reprogramming
(Takahashi and Yamanaka, 2006). Polycistronic inducible lentiviral
vectors bearing 4 genes identiﬁed by the CEMA algorithm for two cell
types: early (6 to 8 week gestation) neural progenitor cells (eNPC)
and endothelial cells were created. The vectors also included a puromy-
cin selection gene and a reporter YFP allele. Early passage primary neo-
natal dermal ﬁbroblasts (NHDF) were driven to express the reverse
tetracycline transactivator (rtTA) upon doxycycline (dox) by lentiviral
infection and were stably selected with G418. Similarly, hESC and iPSC
rtTA expressing clones were also derived (see schematic in Fig. 3A).
Following infection and activation of ectopic expression of the
polycistron containing the eNPC factors predicted by CEMA, YFP posi-
tive ﬁbroblasts were sorted and subsequently cultured conditions
supporting reprogramming (Fig. 3A). Induced early-NPC (iNPC) ﬁbro-
blasts exhibited distinct morphology changes apparent as early as
10 days post induction of ectopic expression (Fig. 3B); upregulated
expression of neural markers such as SOX1, PAX6 andMAP2; downreg-
ulated ﬁbroblast genes (CD44, CD73); and activated endogenous
versions of the CEMA-predicted genes (SOX2, HOPX), which would be
a key step of reprogramming (Fig. 3C and D). However, the iNPCs
were unable to induce expression of NPC markers to a similar level
found in tissue-derived NPCs. Moreover, the iNPCs appeared to proceed
spontaneously to a neuronal fate as judged by staining for MAP2,
suggesting that reprogramming to a stable NPC state was not achieved
(Fig. 3). These results were consistent across at least three independent
reprogramming attempts. To further analyze the degree of cell fate con-
version achieved, we compared the gene expression of reprogrammed
cells to control ﬁbroblasts using microarray, and found signiﬁcant
changes in gene expression, some of which were retained upon dox
withdrawal, a hallmark for reprogramming (Fig. 3E). Differentially
expressed genes were related to several biological Gene Ontology
(GO) term categories: cell structure, cell adhesion, regulation of
neurogenesis and cell division.
Three to four weeks following CEMA endothelial gene set induction
(Fig. 4A), YFP+ ﬁbroblasts began to decrease their cytoplasmic volume,
exhibited a “cobblestone” like morphology (Fig. 4B), and upregulated
endothelial markers such as CD31 and VE-cad (Fig. 4C) as well as the
endogenous versions of CEMA-predicted genes (TAL1, FLI1). Again, the
degree of induction of endogenous endothelial markers, across three
independent experiments, was signiﬁcantly lower than that found in
bona ﬁde endothelial cells (HUVEC), consistent with results from
reprogramming to NPCs from FBs with CEMA-predicted factors. Taken
together, these results suggest that at least partial reprogramming
can be achieved using CEMA selected genes, but that complete
reprogramming is not possible without potentially signiﬁcantmodiﬁca-
tions to the protocol or addition of more factors.2.6. Using CEMA predicted factors to program cell fate
Reprogramming cells from one somatic fate to another requires
massive molecular changes. It is quite possible that the CEMA-selected
factors are important for cell fate, but cannot reprogram fate from an al-
ternate somatic state. Therefore, we hypothesized that these factors
could drive fate more robustly when starting with cells at the pluripo-
tent state. We generated human PSC clones with stable expression of
rtTA and infected them with cocktails of CEMA selected gene sets
through polycistronic lentiviral induction. After selection for infected
cells, and subsequent doxycycline induction, YFP+/YFP− populations
were sorted out and cultured in spontaneous differentiation conditions
(without bFGF). After 2 weeks, mediumwas replaced to target cell cul-
turing conditions.
In concordance with our hypothesis, hPSC engineered to express
CEMA-selected NPC factors, differentiated homogenously to NPCs
exhibiting typical NPC morphology 2–3 weeks post ectopic induction
(Fig. 5A and B), and expressed NPC markers in a level similar to that of
early tissue-derived NPC as shown by RT-PCR (Fig. 5C). In stark contrast
with typical hPSC derived NPCs, which tend to differentiate mainly to-
wards the neuronal lineage (Patterson et al., 2012), NPCs generated by
forced expression of CEMA predicted factors instead exhibited a high
tendency to differentiate to astrocytes as measured by GFAP upon
growth factor withdrawal (Fig. 5D). This is a very important distinction
as the CEMA factors were generated from NPCs from tissue with a glial
bias. RT-PCR for gene expression in the induced clones demonstrated
that CEMA-predicted factors promoted robust induction of typical NPC
markers, and to a degree more similar to that found in tissue-derived
NPCs (Fig. 5C). Remarkably, these iNPCs even appeared to suppress ex-
pression of let-7 target genes, as would be expected for NPCs derived
from tissue, as opposed to those differentiated from pluripotent cells
(Fig. 5C)(Patterson et al., 2014). In addition, this pattern of let-7 target
expression is consistent with their terminal differentiation pattern
(Fig. 5D) (Patterson et al., 2014). This indicates that CEMA-predicted
factors not only induced cell fate, but also drove a speciﬁc cell fate, rel-
evant to the cell types from which the CEMA factors were identiﬁed.
Programming cell fate to the neural lineage with these CEMA deﬁned
factors was highly reproducible, as the data presented are representa-
tive of three independent experiments.
Genome-wide proﬁling of iNPCs in comparison to NPCs isolated
from tissue or differentiated under standard conditions from PSCs by
RNA-seq further demonstrated the robustness of the CEMA driven
approach. For comprehensive comparison, RNA-seq reads from 5 addi-
tional primary cells from the ENCODE project were added to the analy-
ses: hair follicular keratinocyte (ENCFF236EYN), dermis ﬁbroblast
(ENCFF000HWI), kidney epithelial cell (ENCFF109IUU), frontal cortex
(ENCFF001RNU), cerebellum (ENCFF001ROK). We performed unsuper-
vised hierarchical clustering using cummeRbund and found that CEMA
derived iNPCs clustered closer to tissue-NPCs compared to PSC-NPCs
made by traditional differentiation (Fig. 5E), particularly when analyz-
ing CEMA identiﬁed genes expression (Fig. 5E, left panel).
Differentiation of hESCs to the endothelial state is notoriously difﬁ-
cult, typically with a low yield. Here, we used H9-hESCs engineered to
inducibly express the CEMA-predicted endothelial factors (same factors
as used for reprogramming) to drive fate. Two days post dox induction
YFP+/− cells were sorted and grown for 5 days in ESC differentiation
medium which was then replaced to EGM2 endothelial growth medi-
um. As shown in Fig. 6A, CEMA-factor induced cultures exhibited high
differentiation capacity toward the endothelial lineage. At early time
points, nearly 50% of YFP positive cells expressed endothelial markers
such as CD31, while at later time points greater that 80% of YFP positive
cells expressed CD31 (Fig. 6A) compared to 5–10% reported for standard
spontaneous differentiation protocols (Levenberg et al., 2010), as well
as other endothelial related genes (Fig. 6B and C). In contrast, YFP- or
GFP-control cells, induced to spontaneously differentiate, had very
rare CD31 positive cells (Fig. 6A and B) in similar conditions. The
Fig. 3. CEMA selected gene sets can induce at least partial reprogramming. (A) Schematic illustration of experimental design and CEMA selected genes cassettes (B–E), reprogrammed
NHDF-iNPC (B), sorted for YFP+ and treated with dox exhibit distinct morphology changes. The images shown are from a representative experiment, selected from over four separate
experiments. (C) Some NHDF-iNPCs acquired neuronal morphology and stained positive for MAP2. Bars represent 50 μm. (D) NHDF-iNPCs expressed various neuronal and NPC
markers as measured by quantitative real time PCR relative to NHDF-GFP; GAPDH expression was used for normalization. Error bars represent standard error of the mean of four
separate reprogramming experiments, one tissue-NPC sample was used for comparison. (E) Venn diagram of genes of which expression level changed 2 fold in NHDF-iNPC in which
Dox was withdrawn (wd) compared to NHDF-GFP.
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periments. To further functionally test the CEMA derived endothelial-
like cells, we tested their ability to form tube-like structures. A standard
tube formation assay in matrigel demonstrated that CD31 sorted
iEndothelial cells were able to form robust vessels, to a degree similarto that observed for HUVEC cells. On the other hand, YFP- or GFP-infect-
ed cells showed no ability to form tubular structures. (Fig. 6D). Finally,
gene expression proﬁling of the differentiated H9-endo cells was ana-
lyzed bymicroarray and compared against CEMA gene expression data-
base, showing high similarity to primary endothelial cells (Fig. 6E).
Fig. 4. CEMA selected genes for NHDF-endothelial reprogramming. (A) CEMA endothelial selected genes. (B) NHDF-endo 8 weeks of doxycycline treatment, some NHDF-endo stained
positive for the endothelial marker CD31. Images of one experiment that is representative of three separate experiments are presented. Bars represent 50 μm. (C) NHDF-endo
upregulates various endothelial related genes, though in lower levels compared to primary HUVECS as measured by quantitative real time PCR relative to NHDF-GFP. These results are
representative of three independent experiments.
Fig. 5. CEMA selected genes expression derive speciﬁc cell fates. (A) 3 weeks post ectopic induction PSC-iNPC clones exhibited homogenous NPC morphology, (B) and expressed NPC
markers. Bars represent 50 μm. (C) CEMA-PSC-iNPC expressed various NPC markers as measured by RT-PCR relative to H9-GFP and compared to 6.5 w tissue derived NPCs and PSC-
NPC derived by standard protocol. Error bars represent standard error of the mean of three samples. GAPDH was used for normalization. (D) Following growth factor withdrawal, PSC-
iNPC exhibited high tendency to differentiate towards the glial lineage (GFAP positive cells) quantiﬁcation of three separate experiments with different PSC clones shown. For
experiment #4, CEMA-XFiPS cells were chemically induced to differentiate towards NPC using small molecules (Chambers et al., 2009). YFP+/− NPCs were sorted out followed by
growth factor withdrawal. (E), Hierarchical clustering of gene expression proﬁles as measured by strand-speciﬁc RNA-seq, shown as dendrograms. Left panel: CEMA selected early
tissue NPC genes (see Fig. S1); right panel: total gene expression.
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We have generated a compendium of 17 cell-state-speciﬁc gene
expression data, and analyzed it to identify unique gene expression
patterns. This approach focused on (1) cell-state-speciﬁc data, and
(2) data from a single laboratory and platform. The latter is an important
distinction because of well-known issues with inter-laboratory effects
that plague meta-analyses (Guenther et al., 2010). The focus on data
from a single laboratory can be viewed either as a restriction, or as a ben-
eﬁt. In general, integration of independentmicroarray studies is challeng-
ing and there is increasing acceptance that only data from the same
platform can be integrated (Lukk et al., 2010). It has, however, been
shown that when data are combined from different laboratories, and
where biological experiments are replicated across laboratories, that the
biological effects are stronger than the laboratory effects. Nevertheless,
for such a merger to be informative, one must have the same biological
condition across several labs, otherwise, lab-speciﬁc effects cannot be dis-
tinguished from biological effects because both are being changed at the
same time. Because our focus was to investigate cell-speciﬁcity through
developmental stages and across regional speciﬁcation, it was difﬁcult
to amass such redundant public data across laboratories. Additionally,
when we tried including new cell types generated in other laboratories,
apparent artifacts were introduced in to the analysis. As such, we focused
our analysis on the rich cell-state-speciﬁc compendiumof data generated
in our laboratory, for which no such artifacts were apparent.
Using murine ESCs, Correa-Cerro et al. (2011) screened the effect of
single overexpressed TFs from a panel of 137 transcription factors and
selected for those which had the ability to induce a transcriptome
shift towards speciﬁc lineages at 48 h post induction. They followed
that report by testing some of their selected TF by directly differentiat-
ing four distinct cell types and verifying some successful differentiation(Yamamizu et al., 2013). The authors suggested that upon identiﬁcation
and expression of a downstream cell-speciﬁc gene combination of TF,
rapid speciﬁc differentiation to mature cell subtypes can be achieved.
As thismanuscriptwas in preparation, two groups published impor-
tant studies showing that a similar type of algorithm applied to identify
transcription factors speciﬁc to particular cell types proﬁled and depos-
ited into public databases. Both studies also showed that cell state
expression patterns can be used to predict transcription factors able to
reprogram cell fate from ﬁbroblasts to retinal pigment epithelial cells
(RPE) or keratinocytes (D'Alessio et al., 2015; Rackham et al., 2016).
Both of these studies took advantage of large public databases contain-
ing data from at least 100 cell states to compile lists of transcription
factors with cell-type speciﬁc expression patterns. Rackham et al. also
made a tool to allow simple prediction of TFs that could effectively re-
program cell fate, and used it to demonstrate the accuracy of prediction
(Mogrify) (Rackham et al., 2016). Together, these studies demonstrated
that reprogramming factors can be identiﬁed solely on the basis of their
gene expression pattern.
In the current study, we narrowed the pool of cell-type speciﬁc tran-
scription factors to those that are particular to individual cell states, such
as different developmental stages of neural progenitors. In doing so, we
identiﬁed cocktails of transcription factors that can be introduced into
the pluripotent state and drive nearly uniform cell fate towards particu-
lar states. This allowed for the generation of neural progenitors that
were more advanced developmentally at the transcriptional level, and
in addition, were more prone to generating astrocytes.
Some examples for human ESC directed differentiation have been
reported as well. Ectopic expression of a cocktail of neurogenin-2
(Ngn2) or NeuroD1 (Zhang et al., 2013) and ASCL1 (Chanda et al.,
2014) result in efﬁcient rapid induction of mature speciﬁc subtype of
neuronal cells. Similarly, the 4 endothelial factors selected by CEMA
720 I. Germanguz et al. / Stem Cell Research 16 (2016) 712–724(ERG–FLI1–HHEX–TAL1) were previously tested individually for their
ability to induce hemato-endothelial programs in hPSC (Elcheva et al.,
2014), however only induction of ERG was successful in promoting
endothelial-like cells. The authors further reported that a single factor
induction was not sufﬁcient for a faithful induction of mature endothe-
lial fate as witnessed by the failure of the differentiated cells to turn off
their pluripotent gene expression program. In contrast, expression of
combination of four endothelial CEMA-selected genes drove homoge-
neous differentiation toward the endothelial fate.Fig. 6. CEMA selected genes expression enhance differentiation of human PSCs. (A) Flow cy
endothelial conditions for 8 weeks or 10 weeks. (B) CEMA-H9-iendo cells exhibit homogenou
CEMA-PSC-iENDO expressed various endothelial related genes in similar levels compared to p
represent standard error of the mean of three experiments. (D) Matrigel tube formation assa
endo gene expression compared to H9 controls and other cells in the CEMA gene expression dThe results presented here point to factors that not only deﬁne par-
ticular cell lineages such as neural progenitor cells and endothelial cells
but also characterize both a temporal (i.e., developmental) and regional
patterns of core genes. Lastly, we have provided an interactive web-
based tool to allow users to query unique factors of expression, or, sim-
ply to obtain the pattern of expression of a particular gene of interest
across many human cell types.
Our expectation is that the results of the CEMAoutputwill be reﬁned
as more cell types are added. We hope that the scientiﬁc communitytometry analysis of CD31 positive cells in sorted YFP+/YFP− populations cultured in
s cobble-stone morphology and endothelial marker expression. Bars represent 50 μm. (C)
rimary endothelial cells as measured by RT-PCR relative to H9-GFP (PSC-GFP). Error bars
y: H9-endo-YFP+ formed tube like structure similarly to HUVECs. (E) Heat map of H9-
atabase.
Fig. 6 (continued).
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the types of gene expression patterns that deﬁne individual cell states.
Beyond reprogramming and direct differentiation, we expect that
users will beneﬁt from having the ability to phenotype cells derived
from tissue or created from PSCs in their own lab using the new groups
of genes deﬁned here. For instance, if one simply uses SOX2 and NESTIN
as neural progenitor markers, it is clear from the CEMA output, that a
wide array of different types of NPC express these markers. Instead,
one could look to CEMA to provide a more complete picture of a cell
of interest, from the tissue from which it was derived to the stage of
development it might represent.
Our ﬁndings suggest that expression of CEMA selected factors can
improve standard PSC differentiation protocols and facilitate generation
of mature functional differentiated cells with high homogeneity. These
data validate CEMA as a tool to identify genemodules important for par-
ticular cell fates, and point towards methods that could be used to gen-
erate any cell type desired from human pluripotent stem cells as long as
a gene expression proﬁle has been obtained.
4. Materials and methods
4.1. Statistical analysis
To determine the core set of genes uniquely expressed within a
given cell type, one statistical approach would be to apply a t-test for
the one cell type of interest against all others, or use analysis of variancewith post-hoc tests. In fact, there aremany statistical approaches which
would serve a similar purpose (Cavalli et al., 2011; Liu et al., 2008; Lukk
et al., 2010; McCall et al., 2011; Ogasawara et al., 2006; Su et al., 2002).
We used a statistical test that compares the transcriptome of one cell
type to that of every other cell type, on a cell-type-by-cell-type basis,
rather than in a one-against-rest approach. That is, we queried which
genes in one cell type were being expressed differently from every
other cell type, and only then aggregated these pair-wise comparisons
into a single test statistic.
More formally, our null hypothesis for one cell type, i, and one gene,
g, was that themean gene expression in cell type iwas similar to that in
at least one other cell type, j. The test statistic was computed by making
use of themaximum likelihood of a set of logistic regression models for
predicting the cell type from Robust Multiarray Averaged (RMA) ex-
pression values. Within each logistic regression we re-weighted each
cell type so as tomitigate the effect of the number of replicates available
for each class (whichdiffered). This re-weighting ensured that cell types
with more available replicates did not dominate the computation
(a similar re-weighting approach was taken in (McCall et al., 2011)).
In particular, our test statistic, Sig, for gene g and cell type of interest i,
was given by Sgi ≡ ∑
j≠i
Δijg, where Δg
ijwas the change in log likelihood be-
tween two logistic regression models for predicting cell type i: (a) one
which uses the expression levels for gene g and an offset term as fea-
tures (the alternative model), and (b) another which used just an offset
term (the null model). Furthermore, the data used to compute Δgij was
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statistic for cell type iwas aggregated over all cell types j. As mentioned,
we used an array-weighted logistic regression in order to appropriate
equal weight to each cell type regardless of the number of replicates
available. We additionally set Δgij=0 if the mean gene expression was
not higher in the cell type of interest (i) as compared to cell type j, there-
by creating a one-tailed test. This enabled us to ﬁnd genes thatwere not
only uniquely expressed in cell type i, but also expressedmore highly as
compared to all of the other cell types, which prioritized genes for
follow-up.
To compute p-values for our test statistic, we estimated the null
distribution by way of a permutation test, assuming that the null
distribution of the test statistic was the same for each gene when ex-
amining a particular cell type, i. In particular, we estimated the null
distribution for Sig by using 100 permutations of the mapping from
array to cell type. Note that these 100 permutations yielded
5,467,500 empirical null-distributed test statistics because there
were 54,675 probes. Because our null hypothesis is that the mean
gene expression is similar to at least one other cell type, we permut-
ed the mapping for only one cell type j, that is, for only one term Δgij
in the test statistic (where j is chosen at random from among the
other cell types for each permutation). (Using a null hypothesis in
which one instead permuted the mapping for all other cell types
would have yielded more signiﬁcant hypotheses, likely with a simi-
lar rank order to the analysis actually used, but would not have ad-
hered as well to our analysis goals of ﬁnding uniquely-expressed
genes.) We estimated the p-values from this empirical null distribu-
tion of the test statistic in the usual manner, that is, by counting the
proportion of times a test statistic of equal or greater value appears
in the permuted data. From these p-values, we computed the False
Discovery Rate (FDR) for any p-value threshold by way of q-values
(Storey and Tibshirani, 2003), setting π0=1 which yields a conser-
vative FDR estimate. When calling a gene signiﬁcant, we used
q b 0.2. Dendrograms were constructed in Matlab using a
Euclidean distance with complete linkage for the hierarchical clus-
tering algorithm.
Our goal here was not to improve upon existing statistical ap-
proaches in the literature, nor to compare and contrast them, only to
use one that was reasonable for the problem at hand. It is likely that
many other approaches would have yielded similar results, and ulti-
mately, it would in any case be difﬁcult to assess, in silico, which, if
any, is superior. We chose the current approach because: (a) it allowed
us to re-weight each class to mitigate the difference in number of repli-
cates available within each class (a similar re-weighting was done in
(McCall et al., 2011) using ANOVA with a re-sampling-based scheme,
(b) it enabled us to avoid complications in estimating p-values from
multiple ANOVA post hoc tests, and (c), it allowed us to contrast each
cell type against all other cell types on a cell-type by cell-type basis,
rather than against all the rest in aggregate.4.2. General cell culture
For tissue derived cell types, primary cells were derived and cultured
in appropriate culture medium for up to 3 weeks. For pluripotent
derived cell types, hESCs and hiPSCs were cultured under standard
conditions with feeders and driven to differentiate under conditions as
described previously. For both tissue and PSC derived cells, the indicated
cell types were puriﬁed frommixed cultures either by expression of re-
porter construct (such as AFP–GFP for hepatocytes) and FACS, or by
manual dissection based on morphology (such as rosettes for NPCs)
(Patterson et al., 2012). All puriﬁed cell types were judged to be pure
if N90% positive by immunostaining for at least 3 appropriate marker
genes. Many of these cell types were also assayed for appropriate func-
tion (Patterson et al., 2012). Acronyms for all cell types proﬁled are
listed in Table 1.4.3. Pluripotent stem cells
hESCs and hiPSCs were generated as described previously (Chin
et al., 2009; Lowry et al., 2008) and cultured in standard growth condi-
tions on immortalized feeders in DMEM containing Knockout Serum
Replacer. The following lines were proﬁled, and some were used to
make differentiated progeny described below: H1, HSF1, H9, XFiPSC2
(Karumbayaram et al., 2011), hiPSC1, hiPSC2, hiPSC18 (Lowry et al.,
2008), hiPSC19, and hiPSC21 (Chin et al., 2009; Chin et al., 2010). Each
line analyzed was extensively characterized by: immunostaining for
pluripotency factors (OCT4 and NANOG) and cell surface markers such
as Tra-1-81; embryoid body (EB) formation and teratoma analysis was
conducted to demonstrate pluripotency; and karyotyping analysis was
conducted by Cell Line Genetics to ensure a stable karyotype. Immuno-
staining and gene expression analysis demonstrated that these cells
were at least 95% pure (Chin et al., 2009; Lowry et al., 2008).
4.4. Pluripotent stem cell derived deﬁnitive endoderm
hESCs and hiPSCswere starved for serum replacer and administered
activin A. Four days later, these cultures showed a dramatic morpholog-
ical change, and the cells induced expression of deﬁnitive endoderm
markers such as SOX17 and FOXA2. Immunostaining and gene expres-
sion analysis demonstrated that these cells were at least 95% pure
(Chan et al., 2012). These endodermal cultures were assayed for their
ability to be further differentiated into endodermal cell types, such as
hepatocytes (Patterson et al., 2012 and below).
4.5. Pluripotent stem cell derived neural progenitor cells
hESCs and hiPSCs were driven towards the neural lineage by addi-
tion of Neural induction medium (DMEM+ B27, N2, EGF, FGF, retinoic
acid, and Shh). Twoweeks later, neural rosettes formed, andwereman-
ually dissected from the culture and plated onto laminin/ornithine coat-
ed plates. This puriﬁcation scheme produced cultures that were at least
92% pure as judged by immunostaining for a variety of NPC markers
(SOX2, PAX6, SOX1, MUSASHI, etc.) (Patterson et al., 2012). The differ-
entiation capacity of these NPCs was demonstrated upon growth factor
withdrawal, where two weeks later, neurons and glia were generated
(Patterson et al., 2012).
4.6. Pluripotent stem cell derived neurons
PSC-NPCs were subjected to growth factor withdrawal and allowed
to differentiate towards neurons and glia. The cultures were transfected
with DCX-GFP, which shows high speciﬁcity to neurons in culture. Neu-
ronswere then isolated by FACS for GFP positive cells, and collected into
RNA lysis buffer.
4.7. Pluripotent stem cell derived ﬁbroblasts
hESCs and hiPSCs were treated with collagenase to produce ﬂoat-
ing embryoid bodies in non-adherent plates. Two days later, the EBs
were allowed to reattach to culture dishes in ﬁbroblast medium
(DMEM+10% FBS). Colonies with ﬁbroblast morphology were man-
ually isolated and plated into new dishes with FBmedium. Cells were
passaged fourmore times to generate pure cultures morphologically.
Cell purity was assessed by immunostaining and judged to be 99%
pure (Patterson et al., 2012).
4.8. Pluripotent stem cell derived hepatocytes
hESC and hiPSC derived deﬁnitive endoderm was further differenti-
ated towards hepatocytes by the addition of various growth factors
(HGF, KGF, etc.). Additionally, the cultures were transfected with AFP–
GFP construct to highlight the hepatocyte lineage. Hepatocytes
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(Patterson et al., 2012). These hepatocytes were judged to be functional
by both PAS assay and their ability to secrete albumin (Patterson et al.,
2012).
4.9. Pluripotent stem cell derived endothelial cells
PSC differentiating cellswere FACS sorted for CD31 (PECAM) expres-
sion by CD31-PE conjugated antibody (Levenberg et al., 2010).Cells
were grown in EGM2 media (Lonza) for further analysis. Matrigel tube
formation assay was performed as described previously (Levenberg
et al., 2010).
4.10. Tissue-derived cells
Tissue–NPC–fetal brain and spinal cord specimens were obtained as
discarded, anonymized tissues (IRB exempt). These specimens were
physically and chemically dissociated to single cells and placed into
NPC induction medium (see above) on laminin/ornithine coated plates.
These cells were judged to be 100% pure NPCs by immunostaining
(Patterson et al., 2012).
Tissue-ﬁbroblasts, keratinocytes andhepatocyteswere isolated from
discarded anonymized human dermis or liver obtained from Lonza (FBs
and Heps) or Invitrogen (keratinocytes). Fibroblasts were grown in
ﬁbroblastmedia (DMEM+FBS) for twoweeks prior to lysis for RNAex-
traction. Keratinocytes were grown in KSFM (Invitrogen). Hepatocytes
were grown in Bullet Kit (Lonza). Hepatocytes were shown to be func-
tional by albumin secretion and PAS assays, and purity was assayed by
staining for albumin (Patterson et al., 2012). Fibroblasts were assayed
for their ability to secrete appropriate collagens (Patterson et al.,
2012), and keratinocytes were assayed for their function in a calcium
switch assay as described (Blanpain et al., 2006).
Tissue-endothelial cells and smooth muscle cells were isolated and
prepared fromappropriate human tissue by Promocell. Eachwas judged
by themanufacturer to be at least 95% pure by immunostaining for var-
ious markers.
Tissue-mesothelial, kidney epithelial, and myoepithelial cells were
isolated, grown and prepared as described previously (Rheinwald
et al., 1987).
4.11. Microarray proﬁling
Each of these cell types was lysed in the same buffer and RNA was
isolated using the same method (Stratagene). All RNA samples were
submitted to the same facility and hybridized to the same type of
microarray chip (HUG133 2.0plus, Affymetrix) as described previously
(Patterson et al., 2012). Initial standard expression analysis demonstrat-
ed that all cell types were isolated appropriately (Patterson et al., 2012)
and data not shown). The expression data presented reﬂect the average
of at least two biologically independent replicates. Functional annota-
tion was performed using DAVID (Huang da et al., 2009). The microar-
ray data were deposited in NIH-GEO accession number: GSE47796.
4.12. Lentiviral constructs and infection
Polycistronic segments of four CEMA selected genes were custom
synthesized by BioMatik. Reading frames were separated by the 2A
self-cleaving peptide sequence. CEMA selected genes were followed
by a YFP transcript engineered to be expressed in the nucleus. CEMA
polycistrons were cloned into the pLVX-Tight-Puro (Lenti-X™ Tet-On,
Clontech) under the P-Tight composite promoter. Lentiviral particles
were generated in 293T cells using stranded protocols followed by con-
centration with Amicon Ultra-15 centrifugal units (100 K; Millipore).
For constitutive expression of the tetracycline-controlled transactivator
(rtTA), cells were ﬁrst infected with pLVX-Tet-On. Stable clones were
selected by G418.4.13. qRT-PCR analysis
Total RNA was extracted using an RNeasy Mini Kit (QIAGEN). cDNA
synthesiswasperformedusing the Superscript IIIﬁrst-strand cDNAsyn-
thesis kit (Invitrogen). Real-time PCR was performed in triplicate using
the SYBR green real-time PCRMIX (Roche) in the Roche lightcycler 480
machine. Primers are listed in Supplementary Table S2.
4.14. RNA-sequencing
Libraries were constructed according to the manufacturer's instruc-
tions (TruSeq Stranded Total RNA with Ribo-Zero; Illumina). Following
second strand PCR ampliﬁcation, ~200 bp sized libraries were excised
from agarose gel and pooled together in 10 nM concentration each.
Samples were sequenced using Illumina HiSeq2000 on single-end 50-
bp reads and aligned to human reference genome (Hg19) using Tophat
(Trapnell et al., 2009). Processing using Cufﬂinks and Cuffdiff (Trapnell
et al., 2012)was performed to obtain differential fragments per kilobase
of transcript per million mapped reads (FPKM). Further analysis was
performed using the cummeRbund suite (Trapnell et al., 2012). Hierar-
chical distance clustering dendrograms were based on Jensen-Shannon
clusteringmetric. Only genes inwhich FPKMwas over 0.5 in at least one
sample were included.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.scr.2016.04.008.
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